SYRA (Syra Health) ROCE %: 43.58% (As of Mar. 2026)


SYRA Syra Health Corp SYRA
12 GF Score
Price $0.71
GF Value $0.23
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Syra Health ROCE %?

Syra Health SYRA -3.02% 12 ROCE % is 43.58% as of Mar. 2026. GuruFocus rates SYRA with a GF Score™ of 12/100 and a GF Value™ of $0.23 (Significantly Overvalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Syra Health's annualized ROCE % for the quarter that ended in Mar. 2026 was 43.58%.

Syra Health  (OTCPK:SYRA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Syra Health ROCE % Related Terms

Syra Health ROCE % Historical Data

* Premium members only.

The historical data trend for Syra Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syra Health ROCE % Chart

Syra Health Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial -7.41 -486.61 -120.53 -105.79 -34.20

Syra Health Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -67.95 -9.85 -38.76 -24.15 43.58
SYRA
12GF Score
Syra Health Corp SYRA
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Syra Health ROCE % Calculation

Syra Health's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-0.883/( ( (3.679 - 0.614) + (2.773 - 0.675) )/ 2 )
=-0.883/( (3.065+2.098)/ 2 )
=-0.883/2.5815
=-34.20 %

Syra Health's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=0.972/( ( (2.773 - 0.675) + (3.945 - 1.582) )/ 2 )
=0.972/( ( 2.098 + 2.363 )/ 2 )
=0.972/2.2305
=43.58 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 43.58% mean?
Syra Health (SYRA) has a ROCE % of 43.58% as of Mar. 2026.
Is Syra Health's ROCE % too high?
Syra Health's current ROCE % is 43.58%. The Healthcare Providers & Services industry median ROCE % is 6.41. Syra Health's value of 43.58% is 579.9% above this industry median. Overall, Syra Health has a GF Score™ of 12/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Syra Health's ROCE % compare to NIVF and BICX?
Syra Health's ROCE % of 43.58% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. Syra Health's value of 43.58% is 579.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 643 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Syra Health's current ROCE % of 43.58% is 579.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Syra Health's current ROCE % is 43.58%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syra Health stock overvalued right now?
Based on GuruFocus' analysis, Syra Health (SYRA) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.23, compared to a current price of $0.71 — trading 207.7% above its estimated fair value. The current ROCE % is 43.58% and 579.9% above the Healthcare Providers & Services industry median of 6.41. Syra Health's overall GF Score™ is 12/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Syra Health (SYRA), the current ROCE % is 43.58% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Syra Health (SYRA) Overvalued in 2026?

Based on GuruFocus' analysis, Syra Health stock appears to be overvalued. The current stock price of $0.71 is trading 207.7% above its estimated GF Value™ of $0.23. GuruFocus considers Syra Health to be Significantly Overvalued.

Key valuation signals for SYRA:

  • ROCE %: 43.58%
  • GF Value™: $0.23 vs. price of $0.71 (207.7% above fair value)
  • GF Score™: 12/100 with 5 warning signs
  • Industry Position: 579.9% above the Healthcare Providers & Services median

No single metric tells the full story. See the SYRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Syra Health Business Description

Address 1119 Keystone Way North, No. 201, Carmel, IN, USA, 46032
Syra Health Corp is an integrated healthcare solutions company serving government and commercial healthcare organizations. It delivers end-to-end capabilities across population health, behavioral and mental health, digital health, health education and training, and healthcare workforce development and staffing. The various services offered by the company include Syrenity, a mental health application providing preventative care and interventions for behavioral and mental health conditions; SyraBot, a chatbot offering members access to necessary information via the firm's AI-powered customer support chat system; CarePlus, an electronic medical records solution designed for small to mid-sized healthcare organizations; and patient engagement and education services, among others.
12GF Score

Get the complete analysis for SYRA

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.71
Price
$0.23
GF Value